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Deficits in prepulse inhibition (PPI) are a biological marker for schizophrenia. To unravel the mechanisms that control
PPI, we performed quantitative trait loci (QTL) analysis on 1,010 F2 mice derived by crossing C57BL/6 (B6) animals that
show high PPI with C3H/He (C3) animals that show low PPI. We detected six major loci for PPI, six for the acoustic
startle response, and four for latency to response peak, some of which were sex-dependent. A promising candidate on
the Chromosome 10-QTL was Fabp7 (fatty acid binding protein 7, brain), a gene with functional links to the N-methyl-D-
aspartic acid (NMDA) receptor and expression in astrocytes. Fabp7-deficient mice showed decreased PPI and a
shortened startle response latency, typical of the QTL’s proposed effects. A quantitative complementation test
supported Fabp7 as a potential PPI-QTL gene, particularly in male mice. Disruption of Fabp7 attenuated neurogenesis
in vivo. Human FABP7 showed altered expression in schizophrenic brains and genetic association with schizophrenia,
which were both evident in males when samples were divided by sex. These results suggest that FABP7 plays a novel
and crucial role, linking the NMDA, neurodevelopmental, and glial theories of schizophrenia pathology and the PPI
endophenotype, with larger or overt effects in males. We also discuss the results from the perspective of fetal
programming.
Citation: Watanabe A, Toyota T, Owada Y, Hayashi T, Iwayama Y, et al. (2007) Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol 5(11):
e297. doi:10.1371/journal.pbio.0050297
Introduction
Prepulse inhibition (PPI) is the normal suppression of a
startle response when a low-intensity stimulus, eliciting little
or no behavioral response, immediately precedes an un-
expected stronger startling stimulus [1]. The response to the
startling sound is called the acoustic startle reﬂex (ASR). PPI
is observed in all mammals tested to date, and even in
invertebrates [2]. As a behavioral response tool, the ASR is
invaluable, because it can be measured using accessible
electrophysiology tools and, importantly, measurements are
possible under nearly identical conditions between humans
and rodents [3]. Biologically, PPI is a reﬂection of sensory
motor gating mechanisms within the central nervous system,
and deﬁcits within these mechanisms are a consistent feature
of neuropsychiatric illnesses including schizophrenia [4]. As a
reproducible phenotypic marker, impaired PPI is regarded as
an endophenotype for schizophrenia. Endophenotypes are
measurable internal biological markers associated with
complex diseases. They provide simpler genetic clues to
pathogenesis than the disease syndrome itself, allowing for
easier analysis of disease [5]. It is hoped that identifying genes
that underpin PPI could help in deciphering the complex
polygenic mechanisms that predispose to schizophrenia.
To map the genetic loci determining PPI and its related
behavioral proﬁles, we performed large-scale quantitative
trait loci (QTL) analysis using selected inbred mouse strains.
QTL analysis is a method of localizing chromosomal regions
harboring genetic variants that affect a continuously dis-
tributed, polygenic phenotype [6]. Molecular dissection of the
m o u s eg e n o m ei d e n t i ﬁ e dFabp7 as a highly promising
causative gene, especially in males. Functional analysis of
the gene and human studies provided fresh insight into
schizophrenia mechanisms and the PPI endophenotype.
Results
Examination of Mouse Strains for PPI Measurements
In a preliminary study, we examined the supply of inbred
mice for variability in the PPI response between individual
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PLoS BIOLOGYanimals from the same strain and consistency of PPI scores
from animals with different delivery times. These longitudi-
nal tests spanned more than 1 y. Figure 1A and Figure S1A
show the PPI (%) for four different inbred mouse strains of
both sexes, aged between 8–9 wk, from a speciﬁed supplier.
We observed signiﬁcant differences between C57BL/6 (B6)
and the other strains, as well as marginally signiﬁcant sex
effect by analysis of variance based on the linear mixed
model, in PPI magnitude (Table S1, see Materials and
Methods for details). B6 mice exhibited the highest PPI and
C3H/He (C3) the lowest, indicating that these two extreme
strains were suitable for genetic analysis. All mouse strains
and both sexes displayed increased PPI with increased
prepulse levels. By testing 7-wk- and 12–wk-old B6 and C3
animals (Figure 1B and Figure S1B), we conﬁrmed the
stability of PPI during this interval. Based on these results,
we used 8- to 9-wk-old cohorts for all phenotypic evaluations.
PPI and Its Related Phenotypes in F1 and F2 Mice
We prepared a total of 1,010 F2 animals (497 males and 513
females) from F1 parents (B6 females and C3 males). For
phenotypic examinations, we included measurements of ASR
amplitude and latency (the interval from stimulus to
maximum startle amplitude recorded in pulse-alone trials:
see Figure S2), in addition to PPI at different prepulse levels.
The F2 distribution of PPI values was unimodal and roughly
symmetrical (skewness: 2.53 3 10
 4 for prepulse intensity of
86 dB[A]), almost conforming to a normal distribution
(kurtosis:  0.358 for prepulse intensity of 86 dB[A]) (Figure
S3). The other traits also showed normal distributions
(unpublished data). The mean PPI values of F0 (B6 and C3),
F1, and F2 cohorts, ASR amplitudes, and latency are shown in
Figure S3. We calculated broad-sense heritabilities (hB
2)o f
these traits by computing the phenotypic variances (Vp) in the
F1 [Vp(F1)] and F2 [Vp(F2)] population [hB
2 ¼f Vp(F2)  
Vp(F1)g/Vp(F2)] (Table S2): in general, these heritabilities
(0.06–0.43) are low compared with those of other mouse
behaviors [6] and human schizophrenia [7], which are
approximately 0.5 or more. There is a tendency for PPI at
higher prepulse intensities and for the male sex to give a
larger heritability. The genetic correlations (rA) [8] between
PPI and a range of prepulse levels, PPI and ASR, and PPI and
latency are shown in Table S3. The correlation of PPI with
different prepulse levels was relatively high (rA ¼ 0.70–0.83),
which suggests that PPI is regulated by an almost identical set
of genes across different prepulse intensities, an expected
result. In contrast, PPI and ASR (rA ¼ 0.05–0.17) and PPI and
latency (rA¼0.07–0.20) correlations were low, suggesting that
the genetics of ASR and latency are distinct from those of
PPI. Interestingly, we found a modest correlation between
ASR and latency (rA ¼ 0.32). Supporting these suppositions,
phenotypic correlations demonstrated substantial Pearson’s
correlation coefﬁcients (r) between PPI for different prepulse
levels (r¼0.71–0.81) (Figure S4), whereas r was small between
Figure 1. PPI (%) in Mouse Inbred Strains and at Different Ages
(A) Four different strains, both males (M) and females (F) of 8–9 wk, were examined. For the results of analysis of variance, see Table S1. The comparison
of male and female groups in each strain and each prepulse level did not show any significant difference by Student t-test.
(B) Male B6 and C3 mice at 7 wk and 12 wk were examined.
doi:10.1371/journal.pbio.0050297.g001
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Author Summary
A startle response to an unexpected, strong startling stimulus can
be suppressed by an immediately preceding low-intensity stimulus,
thereby eliciting little behavioral response. This phenomenon, called
prepulse inhibition (PPI), has been observed in all mammals tested
and is thought to reflect sensory-motor gating functions in
organisms. PPI is diminished in human schizophrenia, raising the
possibility that PPI might serve as a potential biological marker for
the disease. Once the genes regulating PPI in lower animals are
identified, it is expected that the human orthologs will be strong
candidate genes for schizophrenia. In this study, we first performed
a genetic dissection of mouse PPI using quantitative trait loci
analysis, which detects chromosomal regions harboring causative
genes. Further analyses including those of knockout mice, allowed
us to identify one potential causative gene, Fabp7 (fatty acid binding
protein 7, brain), a chaperon for the essential fatty acid docosahex-
aenoic acid. Human studies showed that the FABP7 gene is modestly
associated with schizophrenia and that transcript expression levels
are up-regulated in schizophrenic brains. From these results, we
propose that a FABP7 protein-mediated disturbance of essential
lipid metabolism in developing brains may be one risk factor in the
development of schizophrenia, with a greater effect in males.PPI and ASR (r ¼ 0.04–0.16) (Figure S5) and between PPI and
latency (r¼0.13) (Figure S5). Phenotypic correlation between
ASR and latency was modest (r ¼ 0.34) (Figure S5). We also
conﬁrmed that ASR was not affected by the body weight of
test animals (r ¼ 0.01) (Figure S5).
First-Stage QTL Genome Scan
All 1,010 F2 generation mice were genotyped using 80
microsatellite markers covering the whole genome (19
autosomes and X chromosome) with an average intermarker
distance of 20 cM [9]. QTL mapping was performed on the
phenotypic and genotypic data using the method of
composite interval mapping (CIM) [10], implemented in the
WinQTLCart 2.5 [11] as the ﬁrst stage QTL genome scan.
Because the X chromosome cannot be appropriately analyzed
by the WinQTLCart, we analyzed the 19 autosomes, including
sex and batch, as ﬁxed effects in the model of CIM. We
classiﬁed 1,010 mice into 21 groups consisting of about 50
individuals and measured the phenotypes of mice from the
same group at the same time. Accordingly, the effects of such
groups were taken into consideration as the batch effects in
the analysis. The results for PPI at ﬁve different prepulse
levels, ASR, and latency measures are shown in Figure S6.
The mean phenotypic value for each QTL and test results
for additive and dominant models are shown in Table 1. The
Chromosome 10-QTL, which elicits the largest genetic
inﬂuence, ﬁts both additive and dominant models, with the
former making a larger contribution than the latter. At this
locus, the B6-derived allele increased PPI. Assuming that
individual PPI-related QTLs act independently, genome-wide
signiﬁcant QTLs (Table 1) account for 26.5% of the
phenotypic variation for PPI, which is comparable to the
heritability of PPI (Table S2). Therefore, it is likely that the
currently detected QTLs account for the almost all genetic
contributions to PPI, and few if any undetected QTLs remain.
We also analyzed the X chromosome using R/qtl software
[12] implemented in the statistical package R2.4.1 (http://www.
r-project.org/), which can suitably handle the X chromosome
in QTL analysis [13]. The results showed no signiﬁcant QTL
on the X chromosome. According to the analysis of variance
for the phenotypes of F2 mice, the sex effect was signiﬁcant in
ASR (p , 0.01) and latency (p , 0.05), but not signiﬁcant in
PPI measures, and the batch effect was conﬁrmed to provide
no signiﬁcant effects on any of the phenotypes. Therefore,
neither the X chromosome nor batch effect was taken into
consideration in the subsequent analyses.
Second-Stage QTL Scanning
Our second-stage analysis involved dense mapping of the
six chromosomes (1, 3, 7, 10, 11, and 13) identiﬁed at stage
one that showed high CIM logarithm of the odds (lod) peaks
for PPI. Additional chromosomes that are suggestive for ASR
and latency were not included, because the evidence
suggesting ASR and latency as endophenotypes in schizo-
phrenia is less strong compared with PPI. We added 51 new
markers, including novel single nucleotide polymorphisms
(SNPs) detected in our polymorphism screen of Cdh23 on
Chromosome 10, and Ofcc1 (Mrds1) and Dtnbp1 on Chromo-
some 13. These also included markers from NCBI (rs33089794
near Fabp7 locus on Chromosome 10), in addition to
microsatellites from the linkage map of Dietlich et al. [9].
They covered the individual QTL intervals at a density of less
than 5 cM. The positions of SNP markers on the linkage map
were determined using Mapmaker/Exp 3.0 software [14]. In
Table 1. QTLs Influencing PPI and Its Related Measures
Trait Nearest Marker
(Mb at Position)
Peak
Position(cM)
Peak Lod Score
(Prepulse Level)
Percent
Variance
B6/B6 (Mean
6 s.e. (n))
B6/C3 (Mean
6 s.e. (n))
C3/C3 (Mean
6 s.e. (n))
Lod Score by Model
(% Variance)
Additive Dominant
PPI D1Mit332 (-) 41.8 7.6 (86 dB) 3.1 32.8 6 1.3 (237) 36.7 6 0.9 (486) 42.5 6 1.3 (223) 7.6 (3.1) —
D3Mit240 (32.1) 13.1 4.1 (82 dB) 1.7 24.9 6 1.2 (250) 30.5 6 0.8 (525) 31.3 6 1.3 (220) 2.9 (2.5) —
D7Mit301 (85.6) 37.9 5.0 (82 dB) 2.2 24.7 6 1.2 (247) 29.6 6 0.8 (491) 32.3 6 1.2 (215) 4.8 (2.6) —
Cdh23
753A/G
(60.4 on
Chromosome 10)
23.0 28.4 (86 dB) 16.3 48.4 6 1.2 (239) 34.5 6 0.8 (551) 30.7 6 1.2 (214) 23.8 (11.3) 7.3 (1.9)
D11Mit242 (63.2) 31.7 3.9 (78 dB) 1.6 27.5 6 1.2 (244) 30.9 6 0.9 (485) 25.9 6 1.1 (243) — 3.2 (1.4)
D13Mit224 (61.5) 41.8 3.8 (78 dB) 1.6 27.1 6 1.3 (231) 27.3 6 0.8 (497) 32.7 6 1.2 (241) 1.7(0.2) 1.5 (0.6)
ASR D1Mit211 (25.8) 6.0 3.5 1.7 797 6 23 (244) 732 6 16 (521) 720 6 23 (221) 3.0 (2.2) —
D2Mit365 (27.7) 15.2 4.7 2.1 685 6 20 (242) 736 6 16 (466) 825 6 25 (230) 4.6 (1.8) —
D7Mit21 (65.9) 0.5 3.9 1.8 728 6 20 (265) 726 6 15 (513) 815 6 22 (220) 2.7(0.6) —
D11Mit242 (63.2) 35.7 7.6 3.6 673 6 21 (244) 736 6 15 (485) 842 6 25 (243) 6.9 (2.2) —
D12Mit214 (78.5) 42.7 4.1 1.8 783 6 24 (255) 748 6 16 (485) 703 6 20 (265) 3.0 (2.5) —
D16Mit76 (66.7) 47.6 4.3 1.8 724 6 22 (238) 735 6 16 (462) 801 6 27 (198) 4.3 (2.0) —
Latency to
response peak
D4Mit166 (92.9) 40.1 8.7 8.5 53.3 6 0.2 (199) 52.7 6 0.1 (439) 52.1 6 0.2 (214) 5.8 (6.6) —
D10Mit214 (25.6) 18.3 4.3 2.8 53.1 6 0.2 (238) 52.6 6 0.1 (508) 52.5 6 0.2 (230) 2.6 (1.9) 2.5 (0.7)
D13Mit103 (76.8) 21.9 4.7 4.2 52.3 6 0.2 (232) 52.3 6 0.1 (460) 53.3 6 0.2 (253) 2.0 (1.2) —
D15Mit107 (84.5) 60.5 5.2 4.7 53.3 6 0.2 (196) 52.6 6 0.1 (478) 52.3 6 0.2 (255) 2.2 (2.9) —
The data are collated from the genotypes of 131 markers used in both the first- and second-stage genome scans. QTLs were detected by composite interval mapping using WinQTLCart
software [11], and peak lod score (% variance) was calculated using a free genetic model. The physical positions of markers are based on the UCSC Genome Browser on Mouse March 2005
Assembly (http://genome.ucsc.edu/cgi-bin/hgGateway). ‘‘—’’ means that the marker has not been localized yet. Peak position shows the distance from the centromere estimated by
marker recombination and the distance between the peak and marker positions was calculated by WinQTLCart. Percentage variance accounted for by each QTL was calculated using the
same software (r
2). Additive and dominant models were also tested, and the lod scores (% variance) of the better-fit model (highest lod score) are shown.
doi:10.1371/journal.pbio.0050297.t001
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Mouse QTL Analysis of PPI and Schizophreniaaddition to CIM (unpublished data), we applied multiple
interval mapping (MIM) [15] implemented in the WinQTL-
Cart [11] to this second-stage analysis, where male and female
mice were analyzed separately. The MIM method also allows
for the epistatic interaction analysis of the QTLs [15]. We
evaluated the goodness-of-model ﬁtting in MIM with Bayesian
information criterion (BIC) [16]. The model with minimized
BIC can be regarded as the best model in MIM. For evaluating
the signiﬁcance of QTL included in the best model, we took
into account the lod score for each ﬁtted QTL, which was
calculated as the twice the difference in the logarithm of
likelihood between the best model and the model eliminating
the QTL from the best model. We set signiﬁcant lod scores
for MIM, according to a genome-wide threshold of p , 0.05
that was calculated in the ﬁrst stage using CIM. Figures 2 and
3 show the results for male and female, respectively, and they
depict only the lod curves on the relevant chromosomes
containing QTLs that exceeded the threshold. For PPI,
Chromosome 3-QTL failed to reach the threshold in females
(Figure 3). For ASR, Chromosome 11-QTL in males (Figure 2)
and Chromosome 1- and 7-QTLs in females (Figure 3) were
lost. For latency, the Chromosome 10-QTL in males (Figure 2)
and the Chromosome 13-QTL in females (Figure 3) were also
lost. The abolition of these QTLs may be related to their
relatively small effect size and/or a differential sex effect. The
fact that the second-stage analysis, where females and males
were analyzed separately, failed to detect any chromosomes
that harbor both ASR- and latency-QTLs is likely related to
the observation that the two phenotypes are inﬂuenced by sex
(evaluated by ANOVA, unpublished data).
Dense mapping permitted us to narrow the peak width at
the Chromosome 10 PPI locus. In males, a sharp peak was
observed around the Fabp7 marker (Figure 2), and in females,
one peak around the Fabp7 locus and a second approximately
20 cM away (between D10Mit175 and D10Mit261) were
detected (Figure 3). (the results of a single QTL in males
and potentially two QTLs in females were conﬁrmed by
performing CIM with the Fabp7 marker (21.9 cM) as a
covariate, and by analyzing male and female data separately.).
In the initial scan, the Chromosome 13-QTL for PPI
contained the Ofcc1 (Mrds1) and the Dtnbp1 genes in its 1-
lod support interval (95% conﬁdence interval): both genes
are susceptibility candidates for human schizophrenia [17].
However, second-stage dense mapping abolished this signiﬁ-
cant PPI-QTL in males and excluded the two genes from the
1-lod support interval of the QTL in females (Figures 2 and
3). Overlapped QTLs for PPI and ASR were still evident on
Chromosome 11 (females) (Figure 3) and for PPI and latency
were still evident on Chromosome 10 (females) (Figure 3),
suggesting that some genes may regulate multiple PPI-related
features.
Epistatic interaction effects between QTLs were included
Figure 2. Dense Mapping in Male Mice
The results from the dense mapping of chromosomes in males that harbor significant QTLs detected in the second scan are shown. The chromosomes
with lod scores not exceeding the threshold are eliminated. The positions of markers used in the first scan are indicated by black triangles, and those
added in the second stage scan (‘dense’) by red triangles. Analysis was performed using the MIM method. M1, rs33089794, the nearest verified SNP to
Fabp7; M2, Cdh23 SNP; M3, Ofcc1 SNP; M4, Dtnbp1 SNP.
doi:10.1371/journal.pbio.0050297.g002
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Mouse QTL Analysis of PPI and Schizophreniain the models for some phenotypes. However, these epistases
revealed no substantial effects on the phenotypes, and
therefore were not analyzed further. The results obtained
by using the MIM method are summarized in Table S4.
We refer to the PPI, ASR, and latency-related QTLs for
combined sexes identiﬁed in this study as Ppi-1 to Ppi-6, Asr-1
to Asr-6, and Latency-1 to Latency-4, based on the magnitude of
the single-locus lod (Table 1). The data are summarized in
Figure S7.
Candidacy of Fabp7 for Ppi-1 and Latency-4 on
Chromosome 10
In the second-stage mapping, we detected a steep lod peak
for PPI (at 86 dB prepulse) around Fabp7 in males (Figure 2)
and the second highest peak at the same locus in females
(Figure 3). We succeeded in narrowing down genes located in
the one drop lod support to approximately 30 (Ensembl
release 45, June 2007, http://www.ensembl.org/Mus_musculus/
index.html) in male data. In our literature survey, none of
those genes (Table S5) was annotated as a modiﬁer of PPI (this
does not necessarily mean that they are true negatives). After
we excluded the possible causality of Cdh23 [18] for the QTL
(see Text S1), we focused on the gene for brain-type fatty acid
binding protein, Fabp7 (also called B-FABP, BLBP)a sa
candidate in this QTL for the following reasons: (1) Disturbed
metabolism of polyunsaturated fatty acid (PUFA), particularly
n-3 PUFA docosahexaenoic acid (DHA), has been suggested in
schizophrenia [19,20,21]. (2) Fabp7 is distinguished from
other fatty acid binding proteins by its strong afﬁnity for
DHA [22]. (3) Mounting evidence suggests the involvement of
NMDA receptor-mediated neuronal pathways in PPI integrity
and schizophrenia pathology [23], and we have obtained data
underscoring the role of Fabp7 in NMDA-mediated neural
signaling (see below in this section and [24]). Fabp7 is strongly
expressed in embryonic and neonatal brains (Figures S8 and
S9). In adulthood, its expression in the brain is primarily
localized to astrocytes [24,25] and is markedly reduced in old
mice (Figure S9). To determine whether the expression of
Fabp7 differed between the B6 and C3 lineages, we examined
mRNA levels by quantitative reverse-transcriptase (RT)-PCR
in the cerebral cortex of embryonic day 16 (E16) and
postnatal day 0 (P0, at birth) animals; the frontal cortex,
hippocampus, and cerebellum of P7 animals; and the frontal
cortex, hippocampus, and olfactory bulb of adult-stage (8 wk)
animals. At all developmental stages and in all anatomical
regions except for P7 frontal cortex and adult frontal cortex
and hippocampus, C3 animals displayed gene up-regulation
compared with those from B6 (Figure 4A). In the adult frontal
cortex, C3 mice showed a trend of increased expression of
Fabp7. In contrast, C3 animals showed signiﬁcantly lower
expression of Fabp7 in P7, relative to B6 animals (Figure 4A).
We hypothesized that Fabp7 expression is strictly controlled
Figure 3. Dense Mapping in Female Mice
The results from the dense mapping of chromosomes in females that harbor significant QTLs detected in the second scan are shown. The chromosomes
with lod scores not exceeding the threshold are eliminated. The positions of markers used in the first scan are indicated by black triangles, and those
added in the second stage scan (‘dense’) by red triangles. Analysis was performed using the MIM method. M1, rs33089794; M2, Cdh23 SNP; M3, Ofcc1
SNP; M4, Dtnbp1 SNP.
doi:10.1371/journal.pbio.0050297.g003
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nal circuitry that controls brain functions, including PPI. To
test whether altered Fabp7 expression affects PPI, we prepared
Fabp7-deﬁcient mice and studied their behavior. Fabp7 (–/–)
mice were viable and showed no macroscopic abnormalities
[24]. Figure 4B and 4C shows that both PPI and latency were
reduced in Fabp7 (–/–) mice. The reduced latency ﬁnding was
consistent with genetic analysis showing that the latency-
controlling QTL was shared with the PPI-QTL on Chromo-
some 10 (Figure 3 and Figure S6) and C3-derived alleles at this
genomic locus attenuated both PPI and latency (Table 1).
Our prior electrophysiological study using hippocampal
CA1 neurons demonstrated a disruption of NMDA-induced
cation current in adult Fabp7 knockout mice [24]. Therefore,
we tested whether Fabp7 (–/–) mice showed additional features
that would ﬁt the NMDA theory of schizophrenia, by
conducting pharmaco-behavioral experiments. A single chal-
lenge of a noncompetitive NMDA receptor antagonist (þ)-
MK-801 did not induce differences in locomotor responses
between Fabp7 (–/–) and wild-type mice (Figure 4D). But
interestingly, repeated administration evoked a greater
Figure 4. Analyses of Fabp7 Expression and Knockout Mouse Behavior
(A) Relative expression levels of Fabp7 at different developmental stages and anatomical regions in B6 and C3 mice. The adult stage mice were all males.
CX, cerebral cortex; HP, hippocampus; CE, cerebellum; FC, frontal cortex; OB, olfactory bulb, *p , 0.05
(B) PPI (%) between wild-type (WT, n¼9: six males and three females) and Fabp7 (–/–) mice (KO, n¼12: six males and six females). The values represent
mean 6 s.e. *p , 0.05.
(C) Latency between male wild-type (WT, n ¼ 9: six males and three females) and Fabp7 (–/–) mice (KO, n ¼ 12: six males and six females). The values
represent mean 6 s.e. *p , 0.05.
(D) Locomotor responses after a single injection of MK-801 in male wild-type (WT, n ¼ 6) and Fabp7 (–/–) mice (KO, n ¼ 6).
(E) Locomotor responses after a challenge injection of MK-801, following five repeated pre-treatments, in male wild-type (WT, n ¼ 6) and Fabp7 (–/–)
mice (KO, n ¼ 6). The genotype effect was significant [F(1,5) ¼ 5.18, p , 0.05]. *p , 0.05 after post hoc analysis.
doi:10.1371/journal.pbio.0050297.g004
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wild-type counterparts (Figure 4E).
Quantitative Complementation of Fabp7
Based on the candidacy of Fabp7 as a Chromosome 10-QTL
gene, we screened it for genetic polymorphisms in B6 and C3
genomic DNA. No polymorphisms were found in an interval
spanning approximately 45 kb, ranging from 23 kb upstream
to 18 kb downstream of the gene. The nearest annotated SNP
to Fabp7, rs33089794 (Figures 2 and 3), is veriﬁed as being
polymorphic between B6 and C3 genomes, and is located 1
Mb upstream (toward the centromere) of Fabp7. Quantitative
genomic PCR conﬁrmed no copy number changes to Fabp7 in
B6 and C3 mouse strains (unpublished data). All Fabp family
genes contain a canonical TATA box followed by a conserved
gene structure, but the control of tissue-speciﬁc and devel-
opmentally regulated expression of various Fabp types
including Fabp7 is poorly understood [26]. Therefore, we
used a quantitative complementation test to determine
whether Fabp7 interacts with a Chromosome 10-QTL gene
affecting PPI-phenotypes at 86 dB [27,28]. The test uses four
strains: B6 and C3 that bear different QTL alleles [referred to
here as high (B6) and low (C3) lines], a strain bearing a
recessive mutation of Fabp7 (m), and a wild-type strain (þ) that
is ideally coisogenic with the mutant. We prepared the latter
two in a B6 background. We determined phenotypes of mice
with the four genotypes; high/m, low/m, high/þ, and low/þ, and
analyzed them in an experiment with two factors: ‘‘Geno-
type,’’ representing the presence or absence of the mutation
at Fabp7, and ‘‘Line,’’ representing natural allelic variation
between B6 and C3 at the QTL. We propose that the QTL
exerts its effect by altering gene expression at a critical
period and area of the brain, as might be the case if it lies in a
distant enhancer element. In this case, the two effects, one
due to the gene and one to the QTL, will not be independent,
and their joint effect (a failure to complement) will be
detected as a signiﬁcant interaction between Line (high or
low) and Genotype (m or þ) in the analysis of variance. The
interaction between Line and Genotype was signiﬁcant in the
combined sexes (p ¼ 0.0087) and male group (p ¼ 0.0232) but
nonsigniﬁcant in the female group (p ¼ 0.128), implicating
Fabp7 as a gene involved in the QTL with larger effects in
male mice (Table 2). We did not observe signiﬁcant
complementation failure in latency parameter. This may be
partly because of the weakness of latency-QTL on Chromo-
some 10 (it failed to reach the genome-wise p , 0.01
threshold in the ﬁrst genome scan).
Fabp7, Neurogenesis, and PPI
To gain further insight into mechanisms that could link
Fabp7 to PPI integrity and schizophrenia pathology, we
examined the effects of Fabp7 disruption on neurogenesis
(deﬁned as the proliferation of neural stem cells to produce
new neurons). The rationale being that the reduction of PPI
and manifestation of other schizophrenia-like behaviors
correlate with a decrease of neurogenesis precipitated by
the deletion of neuronal PAS domain protein 3 transcription
factor [29]. As we have previously shown, Fabp7 is essential for
maintaining embryonic neural stem/progenitor cells in the
developing rat cortex [30]. In addition, the expression of
Fabp7 is regulated by Pax6 [30], one of the key transcription
factors in postnatal neurogenesis [31,32].
We performed immunostaining on the hippocampal
dentate gyrus of Fabp7 (–/–) mice at 4 wk and found a
dramatic decrease in the number of GFAP (glial ﬁbrillary
acidic protein)–positive cells including astrocytes, neural
stem cells, and early progenitor cells. We also noted a
decrease in PSA-NCAM (a polysialylated form of the neural
cell adhesion molecule) positivity, a marker for late progen-
itors (Figure 5A and 5B), implying that Fabp7 deﬁciency
impairs the maintenance of neural stem/progenitor cells.
Next, we investigated cell proliferation in the dentate gyrus at
4 wk. BrdU (5’-bromo-29-deoxyuridine)–incorporation assays
showed an approximately 30% reduction in the number of
dividing cells in the hippocampus of Fabp7 (–/–) mice (Figure
5C and 5D). These results suggest that Fabp7 plays a
signiﬁcant role in neurogenesis, most likely through main-
tenance of neural stem/progenitor cells.
Table 2. Analysis of Variance for Quantitative Complementation of the Fabp7 Mutant
Group Parameter Degrees of Freedom Sum of Squares Mean of Squares F-Value p-Value
Male and Female Group Sex (S) 1 405 405 0.967 0.326
Line (L) 1 6295 6295 15.036 , 0.001
Genotype (G) 1 122 122 0.291 0.590
Run (R) 1 1652 1652 3.947 0.048
L 3 G 1 2919 2919 6.973 0.009
Residuals 295 123508 419 — —
Male Group Line (L) 1 5050 5050 14.101 , 0.001
Genotype (G) 1 264 264 0.738 0.392
Run (R) 1 699 699 1.951 0.165
L 3 G 1 1886 1886 5.266 0.023
Residuals 137 49065 358 — —
Female Group Line (L) 1 1746 1746 3.705 0.056
Genotype (G) 1 0.417 0.417 0.001 0.976
Run (R) 1 921 921 1.956 0.164
L 3 G 1 1106 1106 2.347 0.128
Residuals 158 74443 471 — —
Sex is sex difference, Line is the different QTL effects between B6 and C3 mice, and Genotype is the difference of effects at the Fabp7 locus between wild types and mutants. A total of 311
mice were measured for PPI phenotypes at 86 dB in two runs. Only the results for main effects and L 3 G interaction are listed.
doi:10.1371/journal.pbio.0050297.t002
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With a known association between schizophrenia and
reduced PPI and a possible functional link between PPI and
Fabp7, we examined human FABP7 transcript levels in the
postmortem brains of schizophrenics and controls. Interest-
ingly, FABP7 mRNA was signiﬁcantly up-regulated (p  
0.0001–0.0065, depending on the internal controls used) in
the dorsolateral prefrontal cortex (Brodmann Area 46) of
schizophrenics, relative to the three different internal control
probes (Figure 6A). When analyses were done separately in
Figure 5. Neurogenesis in Wild-Type (WT) and Fabp7 Knockout (KO) Mice
(A and B) In the hippocampal dentate gyrus at 4 wk, Fabp7-null mice show decreased expression of GFAP (a neural stem/early progenitor marker) and
PSA-NCAM (a late progenitor marker).
(C and D) The number of BrdU-incorporated cells is markedly reduced in Fabp7-null mice at 4 wk, suggesting a dramatic decrease in the production of
new neurons.
doi:10.1371/journal.pbio.0050297.g005
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(A) Relative mRNA levels of FABP7 in the BA 46 region of control and schizophrenic postmortem brains.
(B) Genomic structure and location of polymorphic sites in FABP7. Exons are denoted by boxes, with untranslated regions in white and translated
regions in black. The sizes of exons and introns are also shown. ‘‘rs’’ is an NCBI I.D. nomenclature (http://www.ncbi.nlm.nih.gov/) and ’’hCV’’ is derived
from the Celera Discovery System (https://www.appliedbiosystems.com/).
(C) The haplotype block pattern of the FABP7 interval is shown. The number in each cell represents the linkage disequilibrium parameter D’ (3100), red
cells mean D’¼1. Each cell color is graduated relative to the strength of linkage disequilibrium between markers, which is defined by both the D’ value
and confidence bounds on D’. Note that the FABP7 region consists of two haplotype blocks.
(D) Allelic p-values for single-locus and global p-values from multilocus (two, three, and block 1) association analysis. Minor allele frequency data in
control samples for individual SNPs were as follows: SNP1 (C¼0.09), SNP2 (A¼0.34), SNP3 (G¼0.36), SNP4 (T¼0.03), SNP5 (G¼0.38), SNP6 (T¼0.24),
SNP7 (C ¼ 0.10), and SNP8 (C ¼ 0.36).
(E) The site of the missense polymorphism (SNP4), Thr61Met in the FABP7 structure. The methionine residue (white) overlaps with Thr61 (magenta) of
the crystal structure with DHA (yellow) (PDB ID: 1FDQ) [52]. The side-chain rotamer of methionine is arbitrary. A hydrogen bond between Thr61 and a
water molecule is shown as a blue dashed line. The graphic was created using PyMOL (DeLano Scientific).
doi:10.1371/journal.pbio.0050297.g006
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only in males (Figure S10). We propose that the up-regulation
of FABP7 is not due to the effects of neuroleptics, because
chronic administration of haloperidol, a typical neuroleptics,
did not enhance Fabp7 levels in mice (Figure S11).
Next we performed a population-based genetic association
study using 570 schizophrenics and 570 age/sex frequency
matched controls, and analyzing eight SNPs across the gene
(Figure 6B). We detected signiﬁcant associations with SNP4 (p
¼ 0.038), two-locus (p ¼ 0.004– 0.009) and three-locus
haplotypes containing SNP4 (p¼0.013–0.024), and haplotype
block 2 (empirical p ¼ 0.032 after 10,000 permutations) in
which SNP4 resides (Figure 6C and 6D). It is noteworthy that
SNP4 is a missense polymorphism, Thr61Met (182C.T)
(rs2279381). This amino acid residue is conserved as
threonine in the chimpanzee, rat, and mouse. Schizophrenic
patients carried more Thr/Thr genotypes than controls (odds
ratio ¼ 1.85, 95% conﬁdence interval ¼ 1.06–3.24). We
performed further association analysis by dividing samples
according to sex. The signiﬁcant association remained only in
male cohorts (Figure S12). These results suggest that both
expressional changes and genetic variants of FABP7 may
underlie schizophrenia pathology, with larger effects in
males.
Discussion
We have performed comprehensive QTL analyses of PPI,
and other PPI-related measures, ASR and latency. Previously,
only small-sized or provisional mapping studies in rodents
addressed these issues [33–35]. We have also highlighted the
potential molecular mechanisms of PPI and schizophrenia
that are related to NMDA signaling, neurogenesis, and glial
cell integrity, by analyzing a promising gene Fabp7.
Genetic Effects of PPI Determinants
The current ﬁndings of small heritabilities of PPI and its
related features in mice imply a strong environmental
component to PPI, necessitating strict control of breeding
and experimental conditions when conducting PPI experi-
ments as a model of schizophrenia. With regard to delivery
times, our experience stressed the importance of testing the
reliability of the PPI phenotype at different times of arrival.
Extreme developmental situations, such as animal rearing in
isolation and maternal deprivation, are known to affect PPI
integrity [36]. We observed a tendency for higher heritability
in PPI at higher prepulse intensities, which may be relevant to
the generally recognized rule in human subjects [4] and mice
that stronger or more salient prepulses induce greater levels
of PPI. Our results support the validity of this rule.
Joober et al. [33] estimated ASR heritability as 0.207 using
congenic mice with B6 and A/J parents, and this value is very
close to the 0.21 obtained in this study. To date, limited
studies have focused on the characterization of latency.
Zhang et al. [37] reported that a dopamine D1-like receptor
agonist reduced latency but increased the startle amplitude in
rats, both in a dose-dependent manner. We observed a
positive, rather than negative, behavioral correlation between
latency and ASR. Therefore, dopaminergic transmission
provides a limited explanation for the strain differences
between the two physiological measures in B6 and C3 mice.
QTL, QTGs (Quantitative Trait Genes), and QTNs
(Quantitative Trait Nucleotides)
In general, it is difﬁcult to conclusively identify QTGs
(causal genes) and even more so to identify QTNs (causal
sequence variants) from QTL intervals. This is partly because
a QTN could lie within a regulatory region that may be
megabases away from its cognate gene [38], and there may
well be multiple responsible genetic elements within a QTL
and manifold epstatic gene–gene interactions for complex
traits, hampering straightforward identiﬁcation of QTGs/
QTNs by preparing congenic crosses. We initially narrowed
our research to Fabp7, intuitively. Then we used a comple-
mentation test to prove a role for Fabp7 as a QTG on
Chromosome 10. A signiﬁcant failure to complement implies
either allelism (the gene contains the functional variant) or
epistasis (the gene interacts with the functional variant, which
may be elsewhere in the genome). In either case, Fabp7 is
implicated as a modulator of natural variation in PPI.
Fabp7, PPI, and Schizophrenia
Biological support for Fabp7 as the sole substrate or one of
a number of genetic substrates for Ppi-1 and Latency-4 on
Chromosome 10 is demonstrated by the decrease of PPI at all
levels of prepulse (although the result of the 72 dB prepulse
was not signiﬁcant), and the decrease of latency to startle
peak seen in Fabp7-null mice coincides exactly with the effects
of C3-derived alleles, notwithstanding the limited genetic
correlation between the two traits. The down-regulation of
Fabp7 expression in the P7 frontal cortex in C3 mice
compared with B6 suggests an important role for the
developing frontal cortex in PPI regulation by Fabp7, given
that Fabp7-defﬁcient mice displayed disturbed PPI. Fabp7 is
expressed in various regions of the murine brain at the mid-
term embryonic stage; but with progressive differentiation,
Fabp7 expression is gradually attenuated and conﬁned to
astrocytes and neural stem cells. Therefore, the role of Fabp7
in the developing brain is predicted to be crucial. We recently
showed a severe curtailing of cell proliferation in in vitro
Fabp7 knockdown experiments using small interfering RNA,
but conversely an increase in neuronal differentiation [30]
was shown. This study revealed an important function for
Fabp7 in neural precursor cell proliferation. Furthermore,
DHA, a ligand for Fabp7, is reported to promote neuro-
genesis when maternally administrated [39]. These pieces of
evidence suggest that the lowered expression levels of Fabp7
detected in early postnatal stage of C3 frontal cortex might
critically shift the balance from proliferation to differ-
entiation in neuronal progenitors, thereby affecting the
neuronal architecture of mature brains. The correlation
between reduced neural precursor cell proliferation and
impaired PPI has been shown in Npas3-deﬁcient mice [40],
and interestingly, the human ortholog NPAS3 is disrupted by
translocation in affected members of a family with schizo-
phrenia [41]. Another interesting link between neurogenesis
and schizophrenia is reported in the case of neuregulin1 [42–
44].
It would be intriguing to speculate that up-regulation of
FABP7 in the frontal cortex of schizophrenia might be the
consequence of compensatory processes for disturbed FABP7
regulation and/or essential lipid metabolism in the devel-
opmental stages, reminiscent of ‘‘fetal programming’’ that is
observed in metabolic syndromes [45]. It is well known that
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schizophrenia [46,47]. N-3 PUFAs, in particular DHA, are
considered natural ligands for FABP7, are important nutrients
for nervous tissue [48], and have a special role in long-term
synaptic plasticity [49]. Interestingly, our newborn Fabp7 (–/–)
mice showed a 4% decrease (p , 0.05) in DHA content
compared to wild-type counterparts [24]. However, no
signiﬁcant differences were seen in the fatty acid brain
content between the two groups of mice at 10 wk, suggesting
the existence of compensatory mechanisms. The adult Fabp7-
deﬁcient mice, however, still lacked the augmentation of
NMDA current in hippocampal slices that is elicited by DHA
in normal mice [24], implying that the compensation is partial.
In addition to diminished PPI, the increased sensitivity of
Fabp7-null mice to repeated administrations of MK-801
further links this gene to schizophrenia, because chronic
intake of a similar NMDA antagonist, phencyclidine, induces
schizophrenia-like symptoms in humans and exacerbates
symptoms in chronic stabilized schizophrenic patients [50].
FABP7 maps onto human Chromosome 6q22.31, a schizo-
phrenia linkage region supported by a meta-analysis [51].
This study demonstrated that FABP7 could be a novel
schizophrenia susceptibility gene.
The crystal structure of FABP7, harboring Thr61 with oleic
acid and DHA has been reported [52]. The missense
polymorphism (Thr61Met) region is shown in Figure 6E.
The replacement of Thr by Met causes an increase in
hydrophobicity and breakage of a hydrogen bond releasing
a water molecule. These changes may affect protein stability.
In addition, since the polymorphic residue is located near the
fatty acid–binding site, it is likely that the polymorphism
induces an afﬁnity change for fatty acid, which could affect
functionally some biological processes, including the predis-
position to schizophrenia. However, it should be emphasized
that, even if the missense mutation is indeed causative in our
Japanese samples, the effect of Fabp7 on mouse PPI cannot be
solely due to the same mutation, because there are no amino
acid differences between B6 and C3 mice.
FABP7 and Sex
The current animal and human studies both point to a
larger or more substantial contribution by FABP7 to PPI and
schizophrenia in males relative to females. It is well known
that clinical features of schizophrenia differ between the
sexes [53], including the tendency for male patients to show
an earlier onset and a more severe phenotype than females.
Sex differences in human brain development are also
underscored [54]. In addition, fatty acid metabolism includ-
ing FABP is distinct between sexes [55,56]. A database search
(AliBaba2.1: http://www.gene-regulation.com/pub/programs/
alibaba2/index.html) detected three and one potential estro-
gen receptor binding elements (EREs) in the 59 promoter
region (up to 1 kb) and 59-untranslated region (59-UTR) of
mouse Fabp7 gene, respectively, and one potential ERE each
in the promoter region (up to 1 kb) and the 59-UTR of human
FABP7. However, the precise mechanisms of sex-dependent
differential effects of FABP7 on schizophrenic traits remain
quite elusive.
Conclusion
The evidence accumulated in this study consistently
supports causation by Fabp7 as the sole gene or one of the
multiple genetic substrates underlying the Chromosome-10
QTL of PPI. The gene’s effects may be exerted through
differential regulation of transcript levels in B6 and C3 mice
at a critical period. Importantly, the FABP7 gene, which is
modestly associated with schizophrenia in the current study,
has the potential to link together the three compelling
etiological hypotheses of schizophrenia, namely the NMDA,
developmental, and glial (astrocyte) theories [57,58]. The gene
appears to make a larger contribution to PPI and schizo-
phrenia in males. The remaining newly identiﬁed but
uncharacterized QTLs in this study should provide a valuable
resource for continuing molecular studies into PPI and
schizophrenia mechanisms. Finally, there are no established
prophylactic interventions for schizophrenia. Our results
raise the possibility of cohort studies to examine whether
replenishment of DHA in pregnant mothers can be beneﬁcial
in reducing the chance of schizophrenia development in their
offspring, especially for high-risk families. Such analyses
should preferably take into account genotypes that affect
function and expression of FABP7 via both direct and
indirect mechanisms.
Materials and Methods
Mice and PPI measurements. The inbred strains of BALB/
cAnNCrlCrlj, C3H/HeNCrlCrj (C3), C57BL/6NCrlCrlj (B6) and DBA/
2NCrlCrlj, and B6C3 F1 hybrid mice (female B6 3 male C3) and F2
individuals produced by randomly intercrossing the F1s were
obtained from Japan’s Charles River Laboratories. The animals were
housed in groups of four in standard cages in a temperature and
humidity-controlled room with a 12-h light/dark cycle (lights on at
08:00) and had free access to standard lab chow and tap water. All the
experiments were performed between 10:00 and 14:00. The exper-
imental procedures were approved by the RIKEN Animal Ethics
Committee. The apparatus for the detection of the startle reﬂexes
(Med Associates) consisted of six standard cages placed in sound-
attenuated chambers with fan ventilation. Before each testing session,
acoustic stimuli and mechanical responses were calibrated using
speciﬁc devices supplied by Med Associates. A test session was
composed of 49 trials, and each trial comprised prepulse sounds (0,
72, 74, 78, 82, and 86 dB[A]) pulse–(120 dB[A]) paired stimulus or a no
prepulse–no pulse pair were administered (for more details, see
Figure S2). Percentage PPI was calculated as f[(ASR amplitude of trial
without prepulse) – (ASR amplitude of trial with prepulse)]/(ASR
amplitude of trial without prepulse)g 3 100.
Effects of strain and sex on PPI with different prepulse levels:
Analyses. PPI phenotypes at each of the prepulse sounds (72, 74, 78,
82, and 86 dB) were measured for the four inbred strains (B6, C3,
BALB, and DBA), where the numbers of mice measured were 30, 30,
29, and 30 for males in B6, C3, BALB, and DBA, respectively, and were
32, 32, 30, and 32 for females in B6, C3, BALB, and DBA, respectively.
This experiment tested three factors: strain, sex, and prepulse level.
The third factor (prepulse level) is ordinal and further was nested,
since each mouse had multiple measurements. Thus, we applied the
linear mixed model to the test of the difference between strains and
between sexes. Statistical analysis for the linear mixed model was
performed using statistical software R2.4.1 (http://www.r-project.org/)
with package nlme [59]. We obtained the best model well explaining
the measurements on the basis of BIC as
yij ¼ a0 þ Si þ Li þ u0i þð a1 þ u1iÞxj þ eij
where yij is the PPI phenotypes of the ith individual at the jth prepulse
level denoted by xj equal to 72, 74, 78, 82, and 86 dB for j ¼1, 2, 3, 4,
and 5, respectively. a0 is the population average intercept, a1 is the
population average slope, which is the regression coefﬁcient of xj. Si
and Li are the ﬁxed effects of strain and sex of the ith individual,
respectively, for which the B6 female mouse was regarded as control
with Li ¼ 0 for B6 strain and Si ¼ 0 for females. u0i and u1i are the
random effects of the intercept and slope associated with ith
individual, and eij is the within-subject error term. It is assumed that
(u0i, u1i) are independently and identically distributed with a bivariate
normal distribution N(0,r
2D), where D is a 2 3 2 positive deﬁnite
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a normal distribution N(0,r
2), independent of (u0i, u1i ). The analysis
of variance showed a signiﬁcant difference between B6 and the other
strains as well as a marginally signiﬁcant sex effect (Table S1).
We compared the PPIs of 7-wk- and 12-wk-old B6 and C3 male
animals with a similar statistical method, where the effects of strains
and ages were included as ﬁxed effects in the model. As a result, a
signiﬁcant difference between strains was conﬁrmed, whereas the
effect of age did not differ signiﬁcantly between 7- and 12-wk-old
animals.
QTL genotyping. Microsatellite markers were typed on a 3730 xl
DNA analyzer (Applied Biosystems) after PCR ampliﬁcation using
ﬂuorescently labeled primers. For SNP genotyping, we used TaqMan
probes and an ABI 7900 sequence detection system (Applied
Biosystems). Detailed information on the markers used is available
on request.
QTL computation. We used two-stage QTL analyses, the ﬁrst stage
using CIM [10] on the whole genome, followed by the MIM method
[15] on selected chromosomes with 51 additional markers. We denote
alternative alleles at a QTL originating from B6 and C3 as Q and q,
respectively. In the CIM method, the following linear model was
applied:
yi ¼ l þ si þ uia þ vid þ
X m
j¼1
ðuijajþvijdjÞþei
where yi is the phenotype of the ith individual, l is the intercept of
the model, si is the sex effect, ui and vi are dummy variables indicating
the genotype of a putative QTL on the position of interest with (ui, vi)
¼(1, 0), (0, 1) and ( 1, 0) for QQ, Qq, and qq, respectively. a and d are
additive and dominance effects of a QTL, respectively. uij and vij are
the variables indicating the genotype of QTL near by the jth marker
included in the model to absorb the effect of a background QTL in
another region. aj and dj are the additive and dominance effects of the
QTL, and ei is the residual error.
In the second QTL genome scan, we used MIM to analyze the more
detailed genetic structure of the phenotypes, where male and female
mice were analyzed separately. MIM uses multiple marker intervals to
simultaneously construct multiple putative QTLs in the model for
QTL mapping. Therefore, compared with CIM, MIM tends to be more
powerful and precise in detecting QTLs. The analysis with MIM
attempts to ﬁt the following model including effects from multiple
QTLs and the epistasis between QTLs to the observations:
yi ¼ l þ
X N
j¼1
ðuijaj þ vijdjÞþ
X
k,l
X
ðuikuilaakl þ uikviladkl þ vikuildakl
þ vikvilddklÞþei
where N is the number of QTLs involved, aakl is the additive by
additive epistatic interaction between the kth QTL and the lth QTL,
and adkl , dakl, and ddkl are interaction of additive by dominance,
dominance by additive, and dominance by dominance interaction,
respectively, between the kth QTL and the lth QTL, with other
parameters and variables being as described above in the model of
CIM. In MIM, we evaluated the quality of model-ﬁtting with BIC [16],
which is deﬁned as
BIC ¼  2logðlikelihoodÞþklogn
where k is the number of parameters ﬁtted in the model and n is the
sample size. The model that minimized BIC speciﬁes the genetic
architecture, namely the QTL number, N, the position and effect of
each of N QTLs and epistatic interaction between some QTLs.
Quantitative RT-PCR. We determined the levels of mRNA from
mouse and human brain tissue by real-time quantitative RT-PCR
(TaqMan system and ABI 7900) and the standard curve method
described elsewhere [60].
mRNA expression data: Analyses. The differences of the means of
mRNA expression levels in mouse brains were evaluated by either
Student’s t-test (two-tailed) (two groups) or Bonferroni test (more
than two groups). The gene expression levels in human brains were
evaluated using the two-tailed Mann-Whitney U-test.
Preparation of Fabp7 knockout mice. The generation of Fabp7-
disrupted mice is described in detail elsewhere [24]. Brieﬂy, mouse
genomic clones were isolated from a 129/SvJ genomic library. The
targeting vector was constructed by standard techniques. A correctly
targeted ES clone was injected into the blastocyst from B6 mice. The
mice used in this study were backcrossed from a mixed 129/B6
background onto B6 for at least seven generations and were
intercrossed to produce wild-type and Fabp7-null mice.
Behavioral responses to drug. Adult male wild-type and Fabp7
knockout mice (age of 8–9 wk) were used for the locomotor responses
to (þ)-MK-801 (Sigma Chemical). MK-801 was dissolved in physio-
logical saline and injected intraperitoneally at a dose of 0.3 mg/kg. In
chronic experiments, MK-801 was administered six times at 3-d
intervals. Locomotor activities were recorded from 90 min before to
180 min after single injections (acute experiments) or after the sixth
injection (chronic experiments), using Supermex (Muromati Kikai)
[6].
Locomotor activity data: Analyses. Locomotor activity on the
challenge day was analyzed using a repeated measures ANOVA
(genotype 3 time bin) with time bin as the repeated measure,
followed by Bonferroni post hoc tests.
Quantitative complementation testing. In the quantitative com-
plementation test, a total of 311 mice (145 males and 166 females)
were measured for PPI and latency phenotypes at two different times,
where 159 mice (74 males and 85 females) and 152 mice (71 males and
81 females), respectively, were phenotyped in two independent runs.
We analyzed quantitative complementation results with the statistical
software R 2.4.1 using a linear model: y¼lþSþLþGþRþ(S3L)þ
(S3G)þ(S3R)þ(L3G)þ(L3R)þ(G3R)þ(S3L3G)þ(S3L3R)
þ (S 3 G 3R) þ (L3 G 3R) þ(S3 L 3G 3 R) þ e, for data from both
males and females. Here, y is the phenotype; l is the intercept; S is the
sex effect; L is the difference of effects at QTL between two strains—
i.e., high (B6) and low (C3);G is the difference of effects at a gene of
interest (m andþ); R is the effect of runs; (S3L), (S3G), (S3R), (L3
G), (L3R), and (G3R) are the two-way interactions; (S3L3G), (S3
L3R), (S3G3R), and (L3G3R) are the three-way interactions; (S3
L3G3R) is the four-way interaction; and e is the residual. Moreover,
we performed analyses separately for male and female mice using a
model: y¼lþLþGþRþ(L3G)þ(L3R)þ(G3R)þ(L3G3R)þe.
Table 2 shows only the results for main effects and L3G interaction.
The detailed data are available upon request. Failure to complement
is indicated by a signiﬁcant interaction of (L 3 G) in the analysis of
variance.
Analyses of neurogenesis. Immunostaining for NeuN (neuron
speciﬁc nuclear protein), GFAP, PSA-NCAM, and BrdU was
performed as previously described [30]. BrdU was injected into mice
at 4 wk, three times per day for 3 d, and the brains were removed 1 d
after the ﬁnal injection, processed, and stained for BrdU. BrdU-
incorporated cells within the whole dentate gyrus were counted as
previously described [30] and statistically evaluated by Student’s t-test
(two-tailed).
Human postmortem brain and genetic studies. Demographic data
on brain tissues (from the Stanley Medical Research Institute), and
genomic DNA from patients with schizophrenia (n¼570) and age/sex
frequency matched controls (n ¼ 570), both of which were free of
population stratiﬁcation, have been described elsewhere [60]. We
used TaqMan system for SNP genotyping. Single-locus allelic
association was tested using Fisher’s exact test. The haplotype block
pattern of the FABP7 interval was constructed using the Haploview
program (http://www.broad.mit.edu/mpg/haploview/), using the geno-
type data from both case and control samples (1,140 subjects).
Haplotype distributions were evaluated using the expectation-max-
imization algorithm implemented in the COCAPHASE of UN-
PHASED software package v2.403 (http://www.litbio.org). Empirical
signiﬁcance levels were simulated from 10,000 Monte Carlo permu-
tations using the COCAPHASE program. The present study was
approved by the ethics committee of RIKEN.
Supporting Information
Figure S1. Bar Charts of PPI (%) in Mouse Inbred Strains and at
Different Ages
(A) The values represent mean 6 standard error (s.e.) (n ¼ 29–32 for
each group). (B) The values represent mean 6 s.e. (n ¼ 20 for each
group).
Found at doi:10.1371/journal.pbio.0050297.sg001 (839 KB EPS).
Figure S2. Diagram of PPI Measurements
Found at doi:10.1371/journal.pbio.0050297.sg002 (38 KB PPT).
Figure S3. Strain Differences in PPI and Related Measures
(A) Frequency histogram of PPI (%) at prepulse levels of 82 dB for
each generation. The numbers of mice used for behavioral scoring
were 62 for B6, 61 for C3, 210 for F1, and 1,010 for F2.
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Mouse QTL Analysis of PPI and Schizophrenia(B) PPI (%) at ﬁve different prepulse levels in each generation. The
values represent mean 6 s.e.
(C) Acoustic startle amplitude in each generation. The values
represent mean 6 s.e.
(D) Latency to startle reﬂex peak in each generation. The values
represent mean 6 s.e.
Found at doi:10.1371/journal.pbio.0050297.sg003 (468 KB EPS).
Figure S4. Phenotypic Correlations of PPI (%) at Different Prepulse
Levels
Pearson’s correlation coefﬁcients (r) are shown.
Found at doi:10.1371/journal.pbio.0050297.sg004 (144 KB PPT).
Figure S5. Phenotypic Correlations between PPI-related Measures
Pearson’s correlation coefﬁcients (r) are shown.
Found at doi:10.1371/journal.pbio.0050297.sg005 (63 KB JPG).
Figure S6. Lod Score Plots for the Whole Genome
The results for PPI at ﬁve different prepulse levels (72, 74, 78, 82, and
86 dB), ASR (startle stimulus was 120 dB), and latency are shown.
Analysis was performed using the CIM method. Genome-wise
signiﬁcant threshold values were computed by permutation testing
[61] of 5,000 repetitions for each trait, giving values between 3.35 and
4.23 corresponding to the genome-wise signiﬁcance levels of p , 0.05
and 0.01 (Table S6). Peak lods exceeding the threshold for signiﬁcant
linkage (genome-wise p-value , 0.05, see [62]) were found on
Chromosomes 1, 3, 7, 10, 11, and 13 for PPI on at least one prepulse
sound level; on Chromosomes 1, 2, 7, 11, 12, and 16 for ASR
amplitude; and on Chromosomes 4, 10, 13, and 15 for latency. PPI-
QTLs on Chromosomes 1, 3, 7, and 10; ASR-QTLs on Chromosomes
2, 11, and 16; and latency-QTLs on Chromosomes 4, 13, and 15
fulﬁlled the criteria for highly signiﬁcant linkage (genome-wise p-
value , 0.01) (Table S6). Shared QTLs directing different PPI-related
features were seen on Chromosome 10 (PPI and latency), Chromo-
some 11 (PPI and ASR), and Chromosome 13 (PPI and latency).
Notably, the PPI-QTL on Chromosome 10 yielded the highest lod
score of 27 in this study.
Found at doi:10.1371/journal.pbio.0050297.sg006 (87 KB JPG).
Figure S7. Chromosomal Locations of Mapped PPI, ASR, and Latency
Loci
Each vertical bar represents a mouse chromosome, with the
centromere denoted by a black circle. Loci to the left of each
chromosome are those identiﬁed in this study, and loci to the right
are ﬂanking microsatellite and SNP markers.
Found at doi:10.1371/journal.pbio.0050297.sg007 (382 KB EPS).
Figure S8. Expression of Fabp7 Protein in the Embryonic and
Neonatal Mouse Brains
Fabp7 shows abundant expression in E16 (A) and P0 (B) mouse brains.
At both stages, Fabp7 is strongly expressed in the ventricular zone
and radial glia. The procedure for immunohistochemistry is
described elsewhere [24,32].
Found at doi:10.1371/journal.pbio.0050297.sg008 (42 KB JPG).
Figure S9. Northern Analysis of Fabp7 in the Brain of Developing
Mice
Total RNA was extracted from whole brains of C57BL/6 mice at
embryonic day 15 (E15), postnatal day 0 (P0), and postnatal day 70
(P70) by guanidine thiocyanate/phenol/chloroform extraction (tripli-
cated for each stage). The speciﬁc 45-mer oligonucleotide probe for
Fabp7 was complementary to murine cDNA corresponding to
nucleotides 6809–6853 [63]. Note that gene expression for Fabp7 was
abundant in the brain at E15 and gradually decreased at P0 and P70.
Found at doi:10.1371/journal.pbio.0050297.sg009 (11 KB JPG).
Figure S10. Relative mRNA Levels of FABP7 in the BA 46 Region of
Control and Schizophrenic Postmortem Brains
(A) Male samples. p-Values were calculated using the two-tailed
Mann-Whitney U-test. Cont, control; SZ, schizophrenia
(B) Female samples.
Found at doi:10.1371/journal.pbio.0050297.sg010 (493 KB EPS).
Figure S11. Effects of Chronic Haloperidol Administration on
Expression Levels of Fabp7
Haloperidol (Dainippon Pharmaceutical, Japan; 2 mg/ml solution)
was administered to C3 male mice (n ¼ 12) in drinking water at
concentration of 20 mg/l water for 3 wk. This dose corresponded to
1–5 mg/kg weight/day haloperidol intake, and gave serum haloperidol
concentrations of 5.2–15.6 ng/ml at day 21. Control C3 male mice (n¼
12) were given drinking water without haloperidol. On day 21, the
mice were decapitated, and two brain regions (frontal cortex and
hippocampus) were quickly dissected. Relative mRNA expression
levels were evaluated by Student’s t-test (two-tailed).
Found at doi:10.1371/journal.pbio.0050297.sg011 (29 KB PPT).
Figure S12. Association Analyses of FABP7 in Male and Female
Samples
The samples consist of schizophrenia (n ¼ 285 each for males and
females) and age/sex-matched controls (n ¼ 285 each for males and
females). Single-locus allelic association was tested using Fisher’s
exact test. Haplotype distributions were evaluated using the expect-
ation-maximization algorithm implemented in COCAPHASE [64].
Empirical signiﬁcance levels were simulated from 10,000 Monte Carlo
permutations using the COCAPHASE program.
Found at doi:10.1371/journal.pbio.0050297.sg012 (382 KB EPS).
Figure S13. Trial Effects on PPI and ASR in B6 and C3 Mice
The values represent mean 6 s.e. The number of mice used for
behavioral scoring were 62 for B6 and 61 for C3.
Found at doi:10.1371/journal.pbio.0050297.sg013 (480 KB EPS).
Figure S14. Trial Effects on PPI and ASR in Mice with Three Different
Genotypes at the Cdh23 Locus
The values represent mean 6 s.e. The numbers of mice used for
behavioral scoring were 156 for B6/B6, 476 for B6/C3, and 177 for C3/
C3. The Cdh23 genotypes are Cdh23
753A/Cdh23753A for B6/B6,
Cdh23
753A/Cdh23
753G for B6/C3, and Cdh23
753G/Cdh23
753G for C3/C3.
Found at doi:10.1371/journal.pbio.0050297.sg014 (507 KB EPS).
Table S1. Analysis of Variance for the Differences in PPI Phenotypes
between Strains
Found at doi:10.1371/journal.pbio.0050297.st001 (27 KB XLS).
Table S2. Broad Heritability of Prepulse Inhibition, Startle Reﬂex,
and Latency
Found at doi:10.1371/journal.pbio.0050297.st002 (35 KB XLS).
Table S3. Genetic Correlation between PPI-related Measures
Found at doi:10.1371/journal.pbio.0050297.st003 (36 KB XLS).
Table S4. Summary Results Obtained Using the MIM Method
Found at doi:10.1371/journal.pbio.0050297.st004 (45 KB XLS).
Table S5. Genes Located within 1-lod Conﬁdence Interval of the
Chromosome 10-QTL (Male)
Found at doi:10.1371/journal.pbio.0050297.st005 (98 KB XLS).
Table S6. Threshold Lod Score for QTL Analysis
Found at doi:10.1371/journal.pbio.0050297.st006 (34 KB XLS).
Text S1. Exclusion of Cdh23 as a Candidate Gene in PPI and ASR
Found at doi:10.1371/journal.pbio.0050297.sd001 (38 KB DOC).
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